Found: 16
Select item for more details and to access through your institution.
Impact on abiraterone pharmacokinetics and safety: Open-label drug-drug interaction studies with ketoconazole and rifampicin.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 1, p. 63, doi. 10.1002/cpdd.132
- By:
- Publication type:
- Article
Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 6, p. 851, doi. 10.1007/s10637-023-01395-y
- By:
- Publication type:
- Article
A dose escalation/expansion study evaluating dose, safety, and efficacy of the novel tyrosine kinase inhibitor surufatinib, which inhibits VEGFR 1, 2, & 3, FGFR 1, and CSF1R, in US patients with neuroendocrine tumors.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 3, p. 421, doi. 10.1007/s10637-023-01359-2
- By:
- Publication type:
- Article
Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1–Infected Subjects.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 7, p. 1002, doi. 10.1093/infdis/jis432
- By:
- Publication type:
- Article
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect.
- Published in:
- Nature, 2010, v. 465, n. 7294, p. 96, doi. 10.1038/nature08960
- By:
- Publication type:
- Article
Maternal Fluoxetine Infusion Does Not Alter Fetal Endocrine and Biophysical Circadian Rhythms in Pregnant Sheep.
- Published in:
- Reproductive Sciences, 2005, v. 12, n. 5, p. 356, doi. 10.1016/j.jsgi.2005.03.001
- By:
- Publication type:
- Article
HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety exposure–response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 5, p. 629, doi. 10.1007/s00280-022-04427-1
- By:
- Publication type:
- Article
An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pharmacokinetics of abiraterone in healthy Japanese men: dose-proportionality and effect of food timing.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 49, doi. 10.1007/s00280-014-2616-4
- By:
- Publication type:
- Article
Food Effects on Abiraterone Pharmacokinetics in Healthy Subjects and Patients With Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 12, p. 1406, doi. 10.1002/jcph.564
- By:
- Publication type:
- Article
Single-dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 7, p. 732, doi. 10.1002/jcph.253
- By:
- Publication type:
- Article
Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic Model.
- Published in:
- Clinical Pharmacokinetics, 2020, v. 59, n. 9, p. 1149, doi. 10.1007/s40262-020-00881-3
- By:
- Publication type:
- Article
Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects.
- Published in:
- 2020
- By:
- Publication type:
- journal article